Cite
Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location.
MLA
Labadie, Julia D., et al. “Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location.” JNCI Cancer Spectrum, vol. 4, no. 5, Oct. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1093/jncics/pkaa042.
APA
Labadie, J. D., Harrison, T. A., Banbury, B., Amtay, E. L., Bernd, S., Brenner, H., Buchanan, D. D., Campbell, P. T., Cao, Y., Chan, A. T., Chang-Claude, J., English, D., Figueiredo, J. C., Gallinger, S. J., Giles, G. G., Gunter, M. J., Hoffmeister, M., Hsu, L., Jenkins, M. A., & Lin, Y. (2020). Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location. JNCI Cancer Spectrum, 4(5), 1–9. https://doi.org/10.1093/jncics/pkaa042
Chicago
Labadie, Julia D, Tabitha A Harrison, Barbara Banbury, Efrat L Amtay, Sonja Bernd, Hermann Brenner, Daniel D Buchanan, et al. 2020. “Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location.” JNCI Cancer Spectrum 4 (5): 1–9. doi:10.1093/jncics/pkaa042.